ADSL and cancer: Although potential toxicity to mammalian healthy cells may pose a limitation for the use of AMPs in cancer therapy, at subcytotoxic doses, AMPs have proved useful as chemosensitizing agents in combined therapies with other conventional anticancer drugs [35,36].